SACCHARIN
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 182.0 | -0.5 | 0 | 3 | 70.0 | 0 | 0.0 |
- CAS
- 81072
- UNII
- FST467XS7D
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 80 ZINC catalogs
Known Active Genes
This compound has been observed to have activity at 10μM or less against the following gene(s).
| Name | Description | Classification |
|---|---|---|
| A6YCJ1_9METZ | Astrosclerin-3 | Unclassified / Unclassified |
| CA | Carbonic anhydrase | Unclassified / Unclassified |
| NCE103 | Carbonic anhydrase | Enzyme / Enzyme-Other |
| MTCA2 | Carbonic anhydrase 2 | Enzyme / Enzyme-Other |
| CA7 | Carbonic anhydrase 7 | Enzyme / Enzyme-Other |
| CA4 | Carbonic anhydrase 4 | Enzyme / Enzyme-Other |
| MTCA1 | Beta-carbonic anhydrase 1 | Enzyme / Enzyme-Other |
| CA2 | Carbonic anhydrase 2 | Enzyme / Enzyme-Other |
| CA12 | Carbonic anhydrase 12 | Enzyme / Lyase |
| CA6 | Carbonic anhydrase 6 | Enzyme / Lyase |
| CA14 | Carbonic anhydrase 14 | Enzyme / Lyase |
| CA9 | Carbonic anhydrase 9 | Enzyme / Lyase |
| CA1 | Carbonic anhydrase 1 | Enzyme / Lyase |
| CA5B | Carbonic anhydrase 5B, mitochondrial | Enzyme / Lyase |
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02318446 | 2015-03-01 | Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics | Phase 3 | Not Yet Recruiting |
(Browse) Purchasable Analogs in ZINC
Functions of Saccharin
| Nns - Non-nutritive sweetener |
Regulatory Status of Saccharin
| Reg - Food additives for which a petition has been filed and a regulation issued. |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Inhalation | Aerosol, Metered | 0.11% |
| Inhalation | Aerosol, Spray | 0.05% |
| Inhalation | Solution | |
| Oral | Aerosol, Metered | |
| Oral | Granule, For Suspension | 16MG |
| Oral | Powder, For Solution | |
| Oral | Solution | 1% |
| Oral | Solution, Elixir | |
| Oral | Suspension | 0.25% |
| Oral | Syrup | 0.07% |
| Oral | Tablet | 1.6MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | |
| Oral | Tablet, Extended Release | 8MG |
| Sublingual | Tablet | 0.2MG |
| Topical | Ointment | 0.5% |
| Topical | Solution |